Last edition
Articles, Interviews or Blog posts about:
"ASPA"
Securing Trust in Pharma Packaging
Pharmaceutical packaging has undergone a significant transformation in the past few years, especially in response to the growing threat of counterfeit medicines. In an exclusive interview with Pharma Industrial India, Manoj Kochar, Director and Co-Founder, Holoflex, sheds light on cutting-edge anti-counterfeiting technologies and explains his perspective on the industry’s increasing willingness to invest in advanced packaging and authentication solutions.
ASPA | 22/12/2025
ASPA Addressing Cybersecurity Threats in Pharma Authentication Systems
The 6th edition of Traceability & Authentication Forum 2025, happening on March 17–18 in New Delhi, will bring together policymakers, brands, and industry leaders to discuss advancements in traceability and authentication, reveals Manoj Kochar, President, ASPA in his latest interaction with Aishwarya Saxena, Pharma Industrial India.
ASPA | 20/02/2025
Smart Pharma Packaging: Enhancing Efficiency and Reducing Waste, Combating Counterfeiting
With technologies like blockchain, holograms, ISO 22383 standards, and RFID, smart packaging offers the industry a robust defense against counterfeiting, while also contributing to waste reduction and overall efficiency.
ASPA | 04/12/2024
The Counterfeit Crisis: A Call to Action for the Pharmaceutical Industry
Ensuring drug authenticity begins with secure raw material sourcing from reputable suppliers. During manufacturing, stringent monitoring and unannounced inspections are essential.
ASPA | 10/10/2024
ASPA Empowering Consumers with its Initiatives Against Counterfeit Pharmaceuticals
ASPA actively promotes the adoption of security labels among pharmaceutical manufacturers to combat the proliferation of counterfeit drugs. Through industry collaborations and educational initiatives, ASPA raises awareness about the importance of implementing these cutting-edge authentication solutions, says Manoj Kochar, President, ASPA in his latest interview with Aishwarya Saxena, Pharma Industrial India.
ASPA | 27/05/2024
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy